Proheart 6 is a drug owned by ZOETIS INC. It is protected by 1 US drug patent filed in 2019. All patents have expired. Details of Proheart 6’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6340671 | Active | |
About Proheart 6
Proheart 6 is a drug
owned by ZOETIS INC.
Proheart 6 uses
Moxidectin as the active
ingredient.
Active Ingredient:
Proheart 6 uses
Moxidectin as the active ingredient.
Check out other Drugs and Companies using
Moxidectin ingredient.